Fagron N.V.

Notice of Dividend Amount • May 14, 2014

Waregem (Belgium) / Rotterdam (Netherlands)¹ , 13 May 2014 – The Annual General Meeting of Shareholders, held on 12 May 2014, was successful.

The shareholders adopted, amongst other things, the annual accounts 2013 and determined the dividend over 2013 at € 0,72 per share. The shareholders granted full discharge to the directors and the statutory auditor who were active during the financial year 2013.

The gross dividend paid out by Arseus (coupon number 7) will amount to € 0,72 per share. The net dividend will amount to € 0,54 per share, being gross dividend less 25% Belgian dividend withholding tax.

The timetable is as follows: 14 May Ex-dividend quotation 16 May Record date 19 May Dividend payable

The Extraordinary General Meeting did not reach the quorum of attendance, as required by law, at this meeting to hold valid deliberations and adopt valid resolutions. Therefore a new Extraordinary General Meeting will take place on 13 June 2014 at 11:30 CET at the office of civillaw notary Liesbet Degroote at Beneluxpark 13, 8500 Kortrijk.

In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.

1/2

For more information: Marieke Palstra Director Investor Relations +31 88 33 11 213 (Office) marieke.palstra@arseus.com

This press release was sent out by Arseus NV and Arseus BV.

Arseus profile

Arseus is a R&D scientific company delivering innovative solutions and concepts to professionals and institutions in the healthcare sector in 30 countries worldwide. Arseus is subdivided into three divisions: Fagron is global market leader in pharmaceutical compounding. Corilus develops and supplies unique integrated ICT solutions with substantial added value to medical specialists and is market leader in Belgium, France and the Netherlands. HL Technology develops and produces innovative precision components and orthopaedic tools for dental and medical professionals. The Belgian company Arseus NV is located in Waregem, and is listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.